PD 117519

96392-15-3

CAS-Nr.: 96392-15-3

Englisch Name:: PD 117519

Synonyma:: CI 947;PD 11751;PD 117519;PD 117519,R;PD 117519 (CI947);N-[(R)-Indan-1-yl]adenosine;N-[(1R)-Indan-1-yl]adenosine;(R)-N-(2,3-Dihydro-1H-indenyl)adenosine;PD-117519;PD 117519;PD117519;CI 947;CI947;N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine

CBNumber:: CB31872452

Summenformel:: C19H21N5O4

Molgewicht:: 383.4

MOL-Datei:: 96392-15-3.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 58

PD 117519 Eigenschaften

storage temp.: 2-8°C

Löslichkeit: DMF: 10mg/mL; DMF:PBS (pH 7.2) (1:4): 0.2mg/mL; DMSO: 5mg/mL; Ethanol: 0.1mg/mL

Aggregatzustand: A solid

Farbe: White to off-white

InChIKey: FSKMJUWPFLDDRS-BYMDKACISA-N

SMILES: OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)N[C@H]3C4=C(C=CC=C4)CC3)N=C2)[C@H](O)[C@@H]1O

Sicherheit

PD 117519 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N6-Substituted adenosine receptor agonist; a potential antihypertensive agent.

in vitro

PD 117519 (2-10 mg/kg; oral administration; 16-24 hours; male beagle dogs) treatment produces significant hemodynamic changes at Tmax (4 hours) follows by acute coronary vascular injury that is evident at 16 hours postdosing.Treatment with 2 or 10 mg/kg of PD 117519 produces significant increases in mean heart rate and decreases in mean indirectsystolic blood pressure at time of highest drug exposure, 4 hours postdosing.

PD 117519 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

PD 117519 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 58)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD	0371-55159968 18137130222	haifeng.zhang@pannacean.com	China	645	58
Shenzhen Nexconn Pharmatechs Ltd	+86-755-89396905 +86-15013857715	admin@nexconn.com	China	10311	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5738	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
Career Henan Chemica Co	+86-0371-86658258 +8613203830695	laboratory@coreychem.com	China	30239	58
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19741	58
NewCan Biotech Limited	+86-0571-86912261 +8613735419629	sales@newcanbio.com	China	9980	58
LEAP CHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	24727	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38631	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58

(R)-N-(2,3-Dihydro-1H-indenyl)adenosine
N-[(1R)-Indan-1-yl]adenosine
N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine
CI 947
N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine
PD 117519
N-[(R)-Indan-1-yl]adenosine
Adenosine, N-[(1R)-2,3-dihydro-1H-inden-1-yl]-
PD 117519,R
PD 11751
PD-117519;PD 117519;PD117519;CI 947;CI947
N-[(R)-Indan-1-yl] adenosine, Drug, N-substituted adenosine receptor agonist, a potential antihypertensive agent
N-[(R)-Indan-1-yl]adenosine, PD-117519, CI947
CI-947,PD-117519,Adenosine Receptor,Inhibitor,P1 receptor,PD117519,PD 117519,inhibit,CI 947
PD 117519 (CI947)
(2R,3R,4S,5R)-2-(6-(((R)-2,3-Dihydro-1H-inden-1-yl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
96392-15-3
Bases & Related Reagents
Carbohydrates & Derivatives
Intermediates & Fine Chemicals
Nucleotides
Pharmaceuticals